Where Global Innovation
and Capital Meet

Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Amal develops $9.6m series B

Sep 8, 2017 •

Amal Therapeutics, a Switzerland-based cancer-focused biotechnology spinout from University of Geneva, has raised SFr8.8m ($9.6m) in a series B round co-led by pharmaceutical firm Boehringer Ingelheim.

The corporate, which participated through its corporate venturing division Boehringer Ingelheim Venture Fund, co-led the round with Helsinn Investment Fund, the strategic investment arm of pharmaceutical firm Helsinn, and BioMedPartners.

German public-private partnership High-Tech Gründerfonds (HTGF) also took part in the round, as did VI Partners and Schroder Adveq.

The funding constitutes a first…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

Half of Australian universities have a spinout fund — ahead of US and Europe

Australia has one of the world's most mature university investment ecosystems, thanks to large pensions funds, Uniseed and royalties from wifi.

First-time equity deals in UK spinouts fall 22% — report

The number of deals in UK spinouts at the earliest stage of equity investing has been falling over the past few years, highlighting a potential bottleneck in early-stage funding.

Will influx of pension cash keep more high-growth startups in the UK?

Hopes are lifting that increased pension investment will encourage late-stage startups to stay in the country and even seek to list on the London Stock Exchange.

Events

GCV Institute: CVC Investment Programs

Sep 24 -
Sep 25, 2024
Online

Find out more All events

Events

Webinar: Strategic LP/GP relationships - Creating the win-win

Oct 9, 2024
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

Oct 17 -
Oct 21, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Oct 22 -
Oct 23, 2024
Palo Alto, CA (USA)

Find out more All events

Events

GCV Executive Leadership Forum 2024

Oct 24, 2024
Menlo Park, CA (USA)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

Events

GCV Connect: Germany 2024

Oct 29, 2024
Frankfurt (Germany)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Oct 30 -
Oct 31, 2024
Frankfurt (Germany)

Find out more All events

Events

GCV Asia Congress & International Delegation 2024

Nov 11 -
Nov 14, 2024
Tokyo (Japan)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.